chartexchange

Nurix, Sanofi Diverge — And One Breaks Out — On A Shocking Eczema Development

Investor's Business Daily | Nov 4, 2026 10:11 AM EST

Shares of Nurix Therapeutics crashed Wednesday after Sanofi unexpectedly scrapped an experimental eczema drug that two were codeveloping.
The post Nurix, Sanofi Diverge — And One Breaks Out — On A Shocking Eczema Development appeared first on Investor's Business Daily .

Read original article